𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of arsenic trioxide in patients with metastatic melanoma

✍ Scribed by Kevin B. Kim; Agop Y. Bedikian; Luis H. Camacho; Nicholas E. Papadopoulos; Cecilia McCullough

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
170 KB
Volume
104
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and efficacy of arsenic trioxide
Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma
✍ Ahmad A. Tarhini; John M. Kirkwood; Hussein Tawbi; William E. Gooding; Mohammed πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Arsenic trioxide (ATO) cytotoxicity and apoptosis induction has been demonstrated with numerous cancer cell lines, including human melanoma. ## METHODS. A second‐line, phase 2, single‐arm study of ATO was conducted in patients with inoperable American Joint Committee o

A phase II trial of taxol in metastatic
A phase II trial of taxol in metastatic melanoma
✍ Sewa S. Legha; Sigrid Ring; Nicholas Papadopoulos; Martin Raber; Robert S. Benja πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 321 KB πŸ‘ 2 views
Outpatient combination chemoimmunotherap
Outpatient combination chemoimmunotherapy for patients with metastatic melanoma : Results of a Phase I/II trial
✍ Mohammed Kashani-Sabet; Richard W. Sagebiel; Henry E. Collins; Alan B. Glassberg πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## BACKGROUND. Few studies have examined the feasibility, safety, and efficacy of an outpatient biochemotherapy regimen of low dose, subcutaneously administered interleukin-2 (IL-2) for patients with metastatic (Stage IV) melanoma. ## METHODS. Nineteen patients were treated with intravenous cispl

Phase II trial of dimethyltriazenoimidaz
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid
✍ Ronald M. Bukowski; Catherine M. Tangen; Robert F. Peterson; Thomas R. Fleming; πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 347 KB πŸ‘ 2 views

Background. The use of chemotherapy in patients with metastatic carcinoid tumors has been of limited value, and investigiition of new agents is necessary. Previous reports have suggested that dimethyltriazenoimidazole carboxamide (DTIC) may have antitumor activity. Methods. A Phase I1 trial to inve

Phase I trial of subcutaneous recombinan
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma
✍ Omar Eton; Michael G. Rosenblum; Sewa S. Legha; Wehei Zhang; Mary Jo East; Agop πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 3 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been studied adequately. This study sou